| Literature DB >> 36246144 |
Zegun Pan1, Chaowu Yang2, Ruipeng Zhao1, Xiaosong Jiang2, Chunli Yu2, Zhixiong Li1.
Abstract
Skeletal muscle, comprising approximately 40% of body mass, is a highly complex and heterogeneous tissue serving a multitude of functions in the organism. Non-coding RNAs (ncRNAs) are known to participate in skeletal muscle development as critical regulators. However, the regulatory mechanisms of ncRNAs on chicken muscle traits are not well understood. In the present study, we collected the leg muscle from male embryos of Tibetan chicken at embryonic (E) 10 and E18 for RNA sequencing. A total of 6,583 differentially expressed mRNAs (DEMs) including 3,055 down-regulated and 3,528 up-regulated were identified in E18. We identified 695 differentially expressed lncRNAs (DELs) (187 down-regulated and 508 up-regulated) and 1,906 differentially expressed circRNAs (DECs) (1,224 down-regulated and 682 up-regulated) in E18. Among the 130 differentially expressed miRNAs (DEMIs), 59 were up-regulated and 71 were down-regulated in E18. Numerous DEMs and target genes for miRNAs/lncRNAs were significantly enriched in the muscle system process and cell cycle. We constructed a miRNA-gene-pathway network by considering target relationships between genes related to skeletal muscle development and miRNAs. A competing endogenous RNA (ceRNA) network was also constructed by integrating competing relationships between DEMs, DELs, and DECs. Several DELs and DECs were predicted to regulate the ADRA1B, ATP2A2, ATP2B1, CACNA1S, CACNB4, MYLK2, and ROCK2 genes. We discovered the crosstalk between the ncRNAs and their competing mRNAs, which provides insights into ceRNA function and mechanisms in the skeletal muscle development of chicken.Entities:
Keywords: ceRNA; chicken; lncRNA/circRNA; miRNA; skeletal muscle
Year: 2022 PMID: 36246144 PMCID: PMC9558166 DOI: 10.3389/fphys.2022.969854
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Muscle fiber characteristics of Tibetan chicken at E10 and E18. (A) H&E staining of the leg muscle cross-section from E10. (B) H&E staining of the leg muscle cross-section from E18.
FIGURE 2Overview of long RNA sequencing in the leg muscle of Tibetan chicken. (A) The boxplot of TPM (transcripts per million reads) for known protein-coding transcripts. (B) The Venn diagram of detected mRNAs identified in E10 and E18 group. (C) The boxplot of TPM (transcripts per million reads) for known lncRNA transcripts. (D) The Venn diagram of detected lncRNAs identified in E10 and E18 group.
FIGURE 3GO and KEGG pathway analysis of the differentially expressed mRNAs (DEMs) in the chicken leg muscle. (A) Volcano plot of 6,583 DEMs. (B) Top 20 significantly enriched GO terms for DEMs. (C) Top 20 significantly enriched pathways for DEMs.
The top 20 up-regulated and down-regulated mRNAs.
| Category | Transcript id | Gene id | Gene symbol |
|
|---|---|---|---|---|
| Up | ENSGALT00000099192 | ENSGALG00000032619 | SYPL2 | 1.58E-215 |
| ENSGALT00000013599 | ENSGALG00000008351 | CAV3 | 8.42E-214 | |
| ENSGALT00000059202 | ENSGALG00000006753 | ATP5C1 | 9.88E-197 | |
| ENSGALT00000043595 | ENSGALG00000026553 | — | 1.15E-195 | |
| ENSGALT00000006252 | ENSGALG00000003925 | MYPN | 1.79E-193 | |
| ENSGALT00000011524 | ENSGALG00000007114 | APOA1 | 1.67E-185 | |
| ENSGALT00000046346 | ENSGALG00000012211 | PDLIM5 | 1.17E-175 | |
| MSTRG.7615.2 | ENSGALG00000037443 | CRAT | 3.76E-175 | |
| ENSGALT00000049033 | ENSGALG00000043287 | CAV1 | 1.61E-163 | |
| ENSGALT00000005164 | ENSGALG00000003261 | PTRF | 3.52E-158 | |
| Down | ENSGALT00000039950 | ENSGALG00000003475 | ACLY | 4.80E-106 |
| ENSGALT00000000816 | ENSGALG00000000585 | MYL4 | 1.34E-105 | |
| ENSGALT00000020914 | ENSGALG00000012821 | TUBB2B | 2.87E-103 | |
| ENSGALT00000056361 | ENSGALG00000003922 | TOP2A | 6.52E-100 | |
| ENSGALT00000013437 | ENSGALG00000008256 | BLM | 1.49E-99 | |
| MSTRG.20698.2 | ENSGALG00000008367 | MDK | 7.29E-99 | |
| ENSGALT00000073565 | ENSGALG00000008452 | IFT122 | 1.35E-94 | |
| ENSGALT00000036887 | ENSGALG00000015358 | MYH15 | 6.00E-94 | |
| ENSGALT00000003987 | ENSGALG00000002531 | SF3B3 | 1.80E-93 | |
| ENSGALT00000021124 | ENSGALG00000012952 | BASP1 | 1.09E-91 |
The top 20 up-regulated and down-regulated lncRNAs.
| Category | LncRNA id | Log2FC(E18/E10) |
|
|---|---|---|---|
| Up | MSTRG.22805.1 | 4.360492 | 6.6E-131 |
| MSTRG.5174.3 | 4.006953 | 4.8E-101 | |
| MSTRG.22803.1 | 4.511624 | 2.26E-71 | |
| ENSGALT00000101377 | 7.021484 | 1.4E-56 | |
| MSTRG.7257.18 | 2.278456 | 1.75E-43 | |
| MSTRG.7257.17 | 2.040989 | 4.72E-30 | |
| MSTRG.17517.1 | 2.607342 | 3.68E-27 | |
| ENSGALT00000096941 | 2.909254 | 2.21E-26 | |
| MSTRG.7257.16 | 3.693853 | 3.78E-26 | |
| ENSGALT00000096019 | 2.975009 | 1.12E-24 | |
| Down | ENSGALT00000107394 | −1.67209 | 6.65E-29 |
| MSTRG.18494.1 | −1.25628 | 9.32E-21 | |
| NONGGAT000245.2 | −2.89597 | 5.18E-19 | |
| ENSGALT00000102283 | −1.90458 | 9.08E-18 | |
| ENSGALT00000104731 | −2.45094 | 6.52E-17 | |
| ENSGALT00000093279 | −1.67424 | 1.34E-16 | |
| ENSGALT00000092976 | −1.01148 | 1.39E-15 | |
| ENSGALT00000106965 | −1.87355 | 6.05E-14 | |
| NONGGAT002481.2 | −2.93494 | 6.06E-13 | |
| ENSGALT00000102361 | −4.04126 | 5.02E-12 |
The top 20 up-regulated and down-regulated circRNAs.
| Category | CircRNA id | Host gene id | Log2FC(E18/E10) |
|
|---|---|---|---|---|
| Up | 18_616566_650758 | — | 6.604281 | 0 |
| 18_568737_614281 | — | 6.167016 | 1.1E-282 | |
| 18_503467_567696 | — | 2.950716 | 1.7E-225 | |
| 2_14724132_14730427 | ENSGALG00000007331 | 1.424465 | 2.6E-219 | |
| 14_8816217_8818041 | ENSGALG00000030546 | 3.528837 | 3.5E-153 | |
| 2_14715253_14730427 | ENSGALG00000007331 | 2.531163 | 2.2E-122 | |
| 7_15254259_15256437 | — | 5.657796 | 2.3E-119 | |
| 26_5070548_5072732 | ENSGALG00000003498 | 1.893414 | 5.4E-119 | |
| 5_25346596_25348346 | ENSGALG00000052873 | 1.428139 | 1.2E-108 | |
| 7_4707923_4710257 | ENSGALG00000003862 | 1.418158 | 4.05E-82 | |
| Down | 6_31878072_31892396 | ENSGALG00000009495 | −5.08502 | 7.4E-141 |
| 3_88394208_88403946 | — | −2.11108 | 5.54E-74 | |
| 18_385835_464595 | — | −4.0474 | 1.54E-49 | |
| 15_6681798_6681904 | ENSGALG00000004818 | −9.10084 | 4.59E-45 | |
| 4_1306777_1310899 | — | −2.0855 | 4.18E-42 | |
| 22_360264_375976 | ENSGALG00000030603 | −2.26215 | 3.92E-40 | |
| 1_195385200_195385756 | — | −2.99086 | 1.45E-31 | |
| 1_62147456_62157399 | — | −2.67989 | 3.44E-31 | |
| 10_17683216_17696640 | ENSGALG00000038688 | −3.54978 | 5.35E-26 | |
| 10_17668028_17696640 | ENSGALG00000038688 | −2.11303 | 7.33E-26 |
FIGURE 4Overview of small RNA sequencing in the leg muscle of Tibetan chicken. (A) Portions of small RNA types in the useful reads. The percent of miRNA is 90.34%, and the other 9.66% included rRNA, tRNA, snRNA, snoRNA, repbase, exon, and intron. (B) Length distribution of all miRNAs. (C) The Venn diagram of detected miRNAs identified in E10 and E18 group. (D) The relative proportion of the top 20 miRNAs in the total amount of miRNAs.
The top 20 up-regulated and down-regulated miRNAs.
| Category | MiRNA id | Log2FC(E18/E10) |
|
|---|---|---|---|
| Up | gga-miR-133a-5p | 2.732811 | 2.3E-103 |
| gga-miR-133a-3p | 3.584224 | 2.86E-98 | |
| gga-miR-133c-3p | 2.607947 | 1.53E-65 | |
| gga-miR-191-5p | 2.271249 | 1.76E-63 | |
| gga-let-7b | 2.793175 | 4E-58 | |
| gga-miR-1a-3p | 3.904566 | 4E-58 | |
| gga-miR-145-5p | 1.736813 | 1.74E-57 | |
| gga-miR-30b-5p | 2.121494 | 4.18E-43 | |
| gga-miR-23b-3p | 1.898131 | 1.2E-36 | |
| gga-miR-26a-2-5p | 1.244917 | 5.64E-26 | |
| Down | gga-miR-301a-5p | −2.32789 | 2.54E-29 |
| gga-miR-218-5p | −1.55071 | 4.63E-18 | |
| gga-miR-92-5p | −1.7563 | 2.83E-17 | |
| gga-miR-181b-1-3p | −1.74845 | 9.05E-17 | |
| gga-miR-205b | −4.71672 | 4.24E-16 | |
| gga-miR-222a | −1.61754 | 4.87E-16 | |
| gga-miR-1677-3p | −2.4034 | 5.05E-16 | |
| gga-miR-1662 | −2.32382 | 5.81E-15 | |
| gga-miR-1677-5p | −2.60366 | 1.31E-12 | |
| gga-miR-18b-5p | −1.47996 | 1.91E-12 |
FIGURE 5The miRNA-gene-pathway network between 19 DEMs involved in muscle system process, and their corresponding pathways and DEMIs. Blue hexagon, green round rectangle and red ellipse indicate pathway, gene and miRNA, respectively.
FIGURE 6An overview of the competing endogenous RNA (ceRNA) network. Pink triangle, blue rhombus, red ellipse, and green round rectangle indicate circRNA transcript, lncRNA transcript, miRNA and mRNA transcript, respectively.
FIGURE 7The predicted interaction between circRNA transcript, lncRNA transcripts and ADRA1B, ATP2A2, ATP2B1, CACNA1S, CACNB4, MYLK2, and ROCK2 genes. Blue polygon, yellow triangle, red ellipse, and green round rectangle indicate circRNA transcript, lncRNA transcript, miRNA, and mRNA, respectively.
FIGURE 8Validation of RNA-seq data using real time quantitative PCR (RT-qPCR) (A) and correlation between RNA-seq and RT-qPCR results (B).
19 DEMs involved in muscle system process and their corresponding pathways and related DEMIs.
| DEMs | Pathway | Related DEMIs |
|---|---|---|
|
| cGMP-PKG signaling pathway | gga-miR-92-5p |
|
| cGMP-PKG signaling pathway | gga-miR-1625-5p |
|
| cGMP-PKG signaling pathway | gga-miR-1635 |
|
| cGMP-PKG signaling pathway | gga-miR-1635 |
|
| cGMP-PKG signaling pathway | gga-miR-133a-5p, gga-miR-214b-3p, gga-miR-200b-5p, gga-miR-22-3p, novel-1-4798 |
|
| cGMP-PKG signaling pathway | gga-miR-222a, gga-miR-6670-5p, gga-let-7b, gga-let-7f-5p, gga-miR-551-5p, gga-miR-133a-5p |
|
| cGMP-PKG signaling pathway | gga-miR-1c, gga-let-7b, gga-miR-124a-3p |
|
| cGMP-PKG signaling pathway | |
| Focal adhesion | gga-miR-205b, gga-miR-106-3p | |
|
| cGMP-PKG signaling pathway | |
| MAPK signaling pathway | gga-miR-1625-5p, gga-let-7b, gga-miR-205b, gga-miR-1635, gga-miR-143-3p, novel-1-4798, novel-26-28681 | |
|
| MAPK signaling pathway | gga-miR-7b, novel-26-28681 |
|
| Focal adhesion | gga-miR-193b-3p, gga-miR-1662 |
|
| Focal adhesion | |
| MAPK signaling pathway | gga-miR-1635, gga-miR-12277-3p, gga-miR-15c-3p, gga-miR-135a-2-3p, novel-1-4798, novel-26-28681 | |
|
| Cell cycle | gga-miR-338-3p |
|
| cGMP-PKG signaling pathway | gga-miR-6549-5p, gga-miR-140-3p, novel-26-28681 |
|
| cGMP-PKG signaling pathway | gga-miR-1677-3p, gga-miR-302d, gga-miR-30a-3p |
|
| MAPK signaling pathway | gga-miR-210a-5p, gga-miR-18a-3p, gga-miR-338-3p, gga-miR-1635, gga-miR-210a-5p, gga-miR-6555-5p, gga-miR-425-5p |
|
| cGMP-PKG signaling pathway | |
| Focal adhesion | gga-miR-1329-3p, gga-let-7b, gga-miR-6549-5p, gga-miR-1635 | |
|
| cGMP-PKG signaling pathway | |
| Focal adhesion | gga-miR-214b-3p, gga-miR-1677-3p, gga-miR-6705-5p | |
|
| cGMP-PKG signaling pathway | gga-miR-7474-5p |